Cargando…

Low Klotho/Fibroblast Growth Factor 23 Ratio Is an Independent Risk Factor for Renal Progression in Chronic Kidney Disease: Finding From KNOW-CKD

BACKGROUND: We aimed to evaluate soluble Klotho and circulating fibroblast growth factor 23 (FGF23) ratio as a risk factor for renal progression, cardiovascular (CV) events, and mortality in chronic kidney disease (CKD). METHODS: We analyzed 2,099 subjects from a CKD cohort whose soluble Klotho and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Hyo Jin, Kim, Yunmi, Kang, Minjung, Kim, Seonmi, Park, Sue Kyung, Sung, Suah, Hyun, Young Youl, Jung, Ji Yong, Ahn, Curie, Oh, Kook-Hwan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304693/ https://www.ncbi.nlm.nih.gov/pubmed/35872753 http://dx.doi.org/10.3389/fmed.2022.904963

Ejemplares similares

The association between soluble klotho and cardiovascular parameters in chronic kidney disease: results from the KNOW-CKD study
por: Kim, Hyo Jin, et al.
Publicado: (2018)

Metabolic Acidosis Is an Independent Risk Factor of Renal Progression in Korean Chronic Kidney Disease Patients: The KNOW-CKD Study Results
por: Kim, Hyo Jin, et al.
Publicado: (2021)

Serum klotho is inversely associated with metabolic syndrome in chronic kidney disease: results from the KNOW-CKD study
por: Kim, Hyo Jin, et al.
Publicado: (2019)

Left Ventricular Diastolic Dysfunction and Progression of Chronic Kidney Disease: Analysis of KNOW‐CKD Data
por: Kang, Eunjeong, et al.
Publicado: (2022)

Metabolic acidosis is associated with pulse wave velocity in chronic kidney disease: Results from the KNOW-CKD Study
por: Kim, Hyo Jin, et al.
Publicado: (2019)

Measured sodium excretion is associated with cardiovascular outcomes in non-dialysis CKD patients: results from the KNOW-CKD study
por: Kang, Seong Cheol, et al.
Publicado: (2023)

The KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD): A Korean Chronic Kidney Disease Cohort
por: Oh, Kook-Hwan, et al.
Publicado: (2022)

The KNOW-CKD Study: What we have learned about chronic kidney diseases
por: Oh, Kook-Hwan, et al.
Publicado: (2020)

Fibroblast growth factor 23, klotho and heparin
por: Thomas, S. Madison, et al.
Publicado: (2023)

Comparison of outcomes of chronic kidney disease based on etiology: a prospective cohort study from KNOW-CKD
por: Ryu, Hyunjin, et al.
Publicado: (2023)

The association between socioeconomic disparities and left ventricular hypertrophy in chronic kidney disease: results from the KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD)
por: Kang, Eunjeong, et al.
Publicado: (2018)

Correction to: The association between socioeconomic disparities and left ventricular hypertrophy in chronic kidney disease: results from the KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD)
por: Kang, Eunjeong, et al.
Publicado: (2018)

Baseline General Characteristics of the Korean Chronic Kidney Disease: Report from the KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD)
por: Kang, Eunjeong, et al.
Publicado: (2017)

Author Correction: Comparison of outcomes of chronic kidney disease based on etiology: a prospective cohort study from KNOW-CKD
por: Ryu, Hyunjin, et al.
Publicado: (2023)

Persistent Resistant Hypertension Has Worse Renal Outcomes in Chronic Kidney Disease than that Resolved in Two Years: Results from the KNOW-CKD Study
por: Song, Su-Hyun, et al.
Publicado: (2021)

The ratio of urinary sodium and potassium and chronic kidney disease progression: Results from the KoreaN Cohort Study for Outcomes in Patients with Chronic Kidney Disease (KNOW-CKD)
por: Koo, Hoseok, et al.
Publicado: (2018)

Dietary Protein Intake, Protein Energy Wasting, and the Progression of Chronic Kidney Disease: Analysis from the KNOW-CKD Study
por: Lee, Sung Woo, et al.
Publicado: (2019)

Nutritional Status in Adults with Predialysis Chronic Kidney Disease: KNOW-CKD Study
por: Hyun, Young Youl, et al.
Publicado: (2017)

Role of Fibroblast Growth Factor 23 (FGF23) and αKlotho in Cancer
por: Ewendt, Franz, et al.
Publicado: (2021)

Non-High-Density Lipoprotein Cholesterol and Progression of Chronic Kidney Disease: Results from the KNOW-CKD Study
por: Suh, Sang Heon, et al.
Publicado: (2022)

Urinary Phosphorus Excretion and Cardiovascular Outcomes in Patients with Pre-Dialysis Chronic Kidney Disease: The KNOW-CKD Study
por: Suh, Sang Heon, et al.
Publicado: (2023)

Albuminuria as a Risk Factor for Anemia in Chronic Kidney Disease: Result from the KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD)
por: Han, Ji Suk, et al.
Publicado: (2015)

Elevated Fibroblast Growth Factor 23 and Decreased Klotho Levels Are Associated With Diastolic Dysfunction in CKD G4–5D Patients
por: Milovanova, Ludmila Yu, et al.
Publicado: (2020)

Effects of blood urea nitrogen independent of the estimated glomerular filtration rate on the development of anemia in non-dialysis chronic kidney disease: The results of the KNOW-CKD study
por: Kim, Hyo Jin, et al.
Publicado: (2021)

Fibroblast growth factor 23—Klotho and hypertension: experimental and clinical mechanisms
por: Freundlich, Michael, et al.
Publicado: (2020)

Mediation of the relationship between proteinuria and serum phosphate: Insight from the KNOW-CKD study
por: Jung, Ji Yong, et al.
Publicado: (2020)

High serum adiponectin as a biomarker of renal dysfunction: Results from the KNOW-CKD study
por: Song, Su Hyun, et al.
Publicado: (2020)

KNOW-Ped CKD (KoreaN cohort study for outcomes in patients with pediatric CKD): Design and methods
por: Kang, Hee Gyung, et al.
Publicado: (2016)

Bone Mineral Density and All-Cause Mortality in Patients with Nondialysis Chronic Kidney Disease: Results from KNOW-CKD Study
por: Suh, Sang Heon, et al.
Publicado: (2023)

Discrepant glomerular filtration rate trends from creatinine and cystatin C in patients with chronic kidney disease: results from the KNOW-CKD cohort
por: Kang, Eunjeong, et al.
Publicado: (2020)

α-Klotho's effects on mineral homeostasis are fibroblast growth factor-23 dependent
por: Erben, Reinhold G.
Publicado: (2018)

Association of Serum Osteoprotegerin Levels with Bone Loss in Chronic Kidney Disease: Insights from the KNOW-CKD Study
por: Kim, Chang Seong, et al.
Publicado: (2016)

Proteinuria Modifies the Relationship Between Urinary Sodium Excretion and Adverse Kidney Outcomes: Findings From KNOW-CKD
por: Kim, Hyo Jeong, et al.
Publicado: (2023)

Epigenome-wide association study of diabetic chronic kidney disease progression in the Korean population: the KNOW-CKD study
por: Sung, Hye Youn, et al.
Publicado: (2023)

Changes in Fibroblast Growth Factor 23 and Soluble Klotho Levels After Hemodialysis Initiation
por: Kawabata, Chiaki, et al.
Publicado: (2019)

Hyperuricemia has increased the risk of progression of chronic kidney disease: propensity score matching analysis from the KNOW-CKD study
por: Oh, Tae Ryom, et al.
Publicado: (2019)

Association Between High‐Sensitivity Cardiac Troponin T and Echocardiographic Parameters in Chronic Kidney Disease: Results From the KNOW‐CKD Cohort Study
por: Kang, Eunjeong, et al.
Publicado: (2019)

KNOW-CKD (KoreaN cohort study for Outcome in patients With Chronic Kidney Disease): design and methods
por: Oh, Kook-Hwan, et al.
Publicado: (2014)

Urine creatinine concentration influences the prognostic value of proteinuria for MACE prediction from the findings of the KNOW-CKD study
por: Oh, Yun Jung, et al.
Publicado: (2022)

Low-dose aspirin was associated with an increased risk of cardiovascular events in patients with chronic kidney disease and low bodyweight: results from KNOW-CKD study
por: Oh, Yun Jung, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jacf7oc0e5o00paka74db5repd